# ARS Pharmaceuticals, Inc.: Form 8-K, filed Oct 15, 2024

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: 8-K
- Filed: 2024-10-15
- Accepted by EDGAR: Oct 15, 2024, 07:02 ET
- Period: 2024-10-08
- Accession: 0001193125-24-237191
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119312524237191/d902443d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119312524237191/

## Items reported

- Item 1.01: Entry into a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119312524237191/d902443d8k.htm

Filed Oct 15, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-237191. Last ingested by Listed: Nov 5, 2026, 17:04 ET. No prices; not investment advice.